TPOXX 10 mg/mL
tecovirimat monohydrate · INJECTION, SOLUTION, CONCENTRATE · SIGA Technologies, Inc.
TPOXX is a injection, solution, concentrate containing tecovirimat monohydrate at 10 mg/mL, taken intravenous. Manufactured by SIGA Technologies, Inc..
Key Facts
- Brand Name
- TPOXX
- Generic Name
- tecovirimat monohydrate
- NDC Code (Product)
50072-010- Manufacturer
- SIGA Technologies, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214518
- Drug Class
- Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
- Marketing Start
- 05/31/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is TPOXX used for?
TPOXX contains tecovirimat monohydrate. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is TPOXX a controlled substance?
TPOXX is not classified as a controlled substance by the DEA.
What is the generic name for TPOXX?
The generic name for TPOXX is tecovirimat monohydrate. There are no other listed brand versions of tecovirimat monohydrate.
What is the NDC code for TPOXX 10 mg/mL?
The NDC (National Drug Code) for TPOXX 10 mg/mL is 50072-010, listed by SIGA Technologies, Inc..
Other TPOXX Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)